Eastwood Bio-Medical Canada Inc. (EBM.V)
CAD 0.65
(-7.14%)
CAD 0.65
(-7.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -546.59 Thousand CAD | -240.38% |
| 2022 | -160.58 Thousand CAD | 73.73% |
| 2021 | -611.33 Thousand CAD | 28.92% |
| 2020 | -860.03 Thousand CAD | -48.36% |
| 2019 | -579.67 Thousand CAD | 32.75% |
| 2018 | -861.97 Thousand CAD | -76.05% |
| 2017 | -489.62 Thousand CAD | -4.51% |
| 2016 | -468.47 Thousand CAD | -79.92% |
| 2015 | -260.38 Thousand CAD | 49.84% |
| 2014 | -519.09 Thousand CAD | -272.7% |
| 2013 | -139.28 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -54.23 Thousand CAD | 70.56% |
| 2024 Q2 | -130.13 Thousand CAD | -139.94% |
| 2024 Q3 | -115.57 Thousand CAD | 11.19% |
| 2023 Q3 | -117.3 Thousand CAD | 34.62% |
| 2023 FY | -546.59 Thousand CAD | -240.38% |
| 2023 Q1 | -72.4 Thousand CAD | -309.0% |
| 2023 Q2 | -179.41 Thousand CAD | -147.8% |
| 2023 Q4 | -184.23 Thousand CAD | -57.06% |
| 2022 Q3 | -83.09 Thousand CAD | -186.72% |
| 2022 FY | -160.58 Thousand CAD | 73.73% |
| 2022 Q4 | -17.7 Thousand CAD | 78.7% |
| 2022 Q2 | -28.98 Thousand CAD | -180.39% |
| 2022 Q1 | -10.33 Thousand CAD | -92.08% |
| 2021 FY | -611.33 Thousand CAD | 28.92% |
| 2021 Q3 | -176.15 Thousand CAD | 23.57% |
| 2021 Q4 | -5381.00 CAD | 96.95% |
| 2021 Q2 | -230.49 Thousand CAD | -20.33% |
| 2021 Q1 | -191.55 Thousand CAD | 30.66% |
| 2020 Q4 | -276.25 Thousand CAD | -276.47% |
| 2020 Q1 | -243.94 Thousand CAD | -29.96% |
| 2020 Q2 | -258.85 Thousand CAD | -6.12% |
| 2020 Q3 | -73.38 Thousand CAD | 71.65% |
| 2020 FY | -860.03 Thousand CAD | -48.36% |
| 2019 Q1 | 5099.00 CAD | 101.52% |
| 2019 Q2 | -291.77 Thousand CAD | -5822.22% |
| 2019 Q3 | -106.23 Thousand CAD | 63.59% |
| 2019 Q4 | -187.7 Thousand CAD | -76.7% |
| 2019 FY | -579.67 Thousand CAD | 32.75% |
| 2018 Q2 | -210.25 Thousand CAD | -36.22% |
| 2018 FY | -861.97 Thousand CAD | -76.05% |
| 2018 Q4 | -334.8 Thousand CAD | -105.94% |
| 2018 Q3 | -162.57 Thousand CAD | 22.68% |
| 2018 Q1 | -154.34 Thousand CAD | -24.36% |
| 2017 Q1 | -120.61 Thousand CAD | -3.05% |
| 2017 Q2 | -113.01 Thousand CAD | 6.3% |
| 2017 Q4 | -124.1 Thousand CAD | 5.9% |
| 2017 FY | -489.62 Thousand CAD | -4.51% |
| 2017 Q3 | -131.88 Thousand CAD | -16.69% |
| 2016 Q1 | -87.2 Thousand CAD | -67.1% |
| 2016 Q2 | -119.04 Thousand CAD | -36.5% |
| 2016 Q3 | -145.18 Thousand CAD | -21.96% |
| 2016 FY | -468.47 Thousand CAD | -79.92% |
| 2016 Q4 | -117.04 Thousand CAD | 19.38% |
| 2015 Q1 | -176.94 Thousand CAD | 34.02% |
| 2015 Q3 | -9989.00 CAD | 45.83% |
| 2015 Q4 | -52.19 Thousand CAD | -422.47% |
| 2015 Q2 | -18.43 Thousand CAD | 89.58% |
| 2015 FY | -260.38 Thousand CAD | 49.84% |
| 2014 Q1 | -39.84 Thousand CAD | 57.51% |
| 2014 Q2 | -89.74 Thousand CAD | -125.23% |
| 2014 Q3 | -121.33 Thousand CAD | -35.21% |
| 2014 Q4 | -268.17 Thousand CAD | -121.02% |
| 2014 FY | -519.09 Thousand CAD | -272.7% |
| 2013 FY | -139.28 Thousand CAD | 0.0% |
| 2013 Q4 | -93.76 Thousand CAD | -70.32% |
| 2013 Q3 | -55.05 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|